BioSpace News Archive

Genetown

Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results Demonstrating Substantial Increases in Complete Response Rates in Advanced Cutaneous Squamous Cell Carcinoma

Checkpoint Therapeutics, Inc. today announced new, longer-term data for cosibelimab from its pivotal studies in locally advanced and metastatic cutaneous squamous cell carcinoma (“cSCC”).

July 27, 2023
·
8 min read
Business

Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023

Chimerix today announced that it will host a live conference call and audio webcast on Thursday, August 3, 2023 at 8:30 a.m. ET to report financial results for the second quarter ended June 30, 2023, and to provide a business overview.

July 27, 2023
·
1 min read
Drug Development

EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit

EyePoint Pharmaceuticals today announced interim masked safety data and baseline patient demographics from its Phase 2 DAVIO 2 clinical trial of EYP-1901, a potential sustained delivery maintenance treatment for wet age-related macular degeneration (wet AMD).

July 27, 2023
·
8 min read
Drug Development

Merck Announces V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Met Key Immunogenicity and Safety Endpoints in Two Phase 3 Trials

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from two Phase 3 trials evaluating V116, the company’s investigational 21-valent pneumococcal conjugate vaccine in vaccine-naïve and previously vaccinated individuals.

July 27, 2023
·
8 min read
Biotech Beach

Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference

Acutus Medical, Inc. announced today that its management team will present at the 43rd Annual Canaccord Growth Conference on Thursday, August 10, 2023 at 9:30 a.m. Eastern Time at the InterContinental Boston Hotel in Boston, MA.

July 27, 2023
·
1 min read
Business

Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast

Voyager Therapeutics, Inc. today announced it will report second quarter 2023 financial and operating results before the market opens on Thursday, August 3, 2023.

July 27, 2023
·
2 min read
Business

NeuroMetrix Reports Q2 2023 Business Highlights

NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and six months period ended June 30, 2023.

July 27, 2023
·
7 min read
Business

PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

PROCEPT BioRobotics Corporation today reported unaudited financial results for the quarter ended June 30, 2023.

July 27, 2023
·
11 min read
Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference

Axogen, Inc. today announced that Karen Zaderej, Chairman, Chief Executive Officer, and President, will participate in a fireside chat at Canaccord Genuity’s 43rd Annual Growth Conference in Boston, MA, on Wednesday, August 9, 2023, at 2 p.m. ET.

July 27, 2023
·
2 min read
Pharm Country

Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylm™ (epinephrine) Sublingual Film

Aquestive Therapeutics, Inc. today released topline data from its latest clinical crossover pilot trial, Study AQ109103 (the “103 study”), for Anaphylm™ (epinephrine) Sublingual Film.

July 27, 2023
·
9 min read